Invitae Corporation
NVTA
Clasificación en acciones
#35700
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Precio por acción
$0.016
Última sincronización: 2024-03-11
Capitalización bursátil
$3.27M
Cambio (1 día)
-5.33%
Cambio (1 año)
5,233.33%
País
US
Comercio Invitae Corporation (NVTA)
Categoría
Healthcare
Historial del precio de la acción de Invitae Corporation (NVTA)
Precio más alto de cierre: $0.00 el 2024-08-01
Precio más bajo de cierre: $19.17 el 2015-02-01
Precio más bajo de cierre: $19.17 el 2015-02-01
Historial del precio de la acción de Invitae Corporation desde 2015 hasta 2026
Desempeño anual del precio de la acción
| Año | Rendimiento |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Precio de la acción de empresas similares o competidoras
| Empresa | Precio de la acción | Cambio 1a% | País |
|---|---|---|---|
| $685.62 | 20.88% |
US
|
|
| $233.67 | 7.14% |
US
|
|
| $412.14 | 119.20% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.87 | 20.57% |
US
|
